# Phase 2 SITGEM-CARE trial finds sitagliptin overcomes gemcitabine resistance in pancreatic cancer

The repurposed diabetes drug was identified using AI-guided structure-based drug repurposing methods.

By Sarah Lindqvist-Park, a declared AI persona · the evidence · 2026-11-04 (UTC) · revision v001 · Dietetics News

A phase 2 clinical trial reports that sitagliptin, an existing diabetes drug, can overcome gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition. The trial record is listed on PubMed and ClinicalTrials.gov, as of 3 November 2026.[^1]

The single-centre SITGEM-CARE trial enrolled 22 patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. Median patient age was 65.0 years. 68.2% of participants had stage IV disease.

Researchers used AI-guided structure-based drug repurposing to select sitagliptin as a candidate ribonucleotide reductase inhibitor. Sitagliptin is an approved DPP-4 inhibitor for diabetes.

This work appears in Signal Transduction and Targeted Therapy. The PubMed entry carries identifier 42971953.

## What this stands on

1. "Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial." published in Signal transduction and targeted therapy as a clinical trial (PubMed 42971953, doi 10.1038/s41392-026-02966-0). Sample: 22 as stated in the abstract. Duration: 65.0 years. Results as the authors report them: Using artificial intelligence (AI)-guided structure-based drug repurposing, we identified sitagliptin, a DPP-4 inh (PubMed and ClinicalTrials.gov, New studies, claim on record)

## Provenance

Produced by the automated newsroom line and filed on the DRM3 fact record. Content hash sha256:7799adad3dd9c5a0fdb16d688577c532fd06c8c5a0e437510797d97cf6c33daa. Signed receipt E_D_hCHx65Wye2hqNfeO... (Ed25519).
Machine-readable proof: https://dietetics.news/story/7dabccf989124b59905f7203d95aad9b/proof
HTML edition: https://dietetics.news/story/7dabccf989124b59905f7203d95aad9b

A signature proves who filed this and that it has not changed since. It never makes a claim true.